Skip to main content

Error message

Warning: Undefined array key "PANTHEON_ENVIRONMENT" in arentfox_preprocess_html() (line 15 of themes/custom/arentfox/arentfox.theme).
arentfox_preprocess_html()
call_user_func_array() (Line: 261)
Drupal\Core\Theme\ThemeManager->render() (Line: 491)
Drupal\Core\Render\Renderer->doRender() (Line: 248)
Drupal\Core\Render\Renderer->render() (Line: 158)
Drupal\Core\Render\MainContent\HtmlRenderer->Drupal\Core\Render\MainContent\{closure}() (Line: 638)
Drupal\Core\Render\Renderer->executeInRenderContext() (Line: 153)
Drupal\Core\Render\MainContent\HtmlRenderer->renderResponse() (Line: 90)
Drupal\Core\EventSubscriber\MainContentViewSubscriber->onViewRenderArray()
call_user_func() (Line: 111)
Drupal\Component\EventDispatcher\ContainerAwareEventDispatcher->dispatch() (Line: 186)
Symfony\Component\HttpKernel\HttpKernel->handleRaw() (Line: 76)
Symfony\Component\HttpKernel\HttpKernel->handle() (Line: 53)
Drupal\Core\StackMiddleware\Session->handle() (Line: 48)
Drupal\Core\StackMiddleware\KernelPreHandle->handle() (Line: 28)
Drupal\Core\StackMiddleware\ContentLength->handle() (Line: 201)
Drupal\page_cache\StackMiddleware\PageCache->fetch() (Line: 138)
Drupal\page_cache\StackMiddleware\PageCache->lookup() (Line: 87)
Drupal\page_cache\StackMiddleware\PageCache->handle() (Line: 50)
Drupal\ban\BanMiddleware->handle() (Line: 48)
Drupal\Core\StackMiddleware\ReverseProxyMiddleware->handle() (Line: 51)
Drupal\Core\StackMiddleware\NegotiationMiddleware->handle() (Line: 36)
Drupal\Core\StackMiddleware\AjaxPageState->handle() (Line: 51)
Drupal\Core\StackMiddleware\StackedHttpKernel->handle() (Line: 741)
Drupal\Core\DrupalKernel->handle() (Line: 19)
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Customs & Import Compliance Blog
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Search

Breadcrumb

  1. Services
  2. Medical Devices

Insights on Medical Devices

37 total results. Page 1 of 2.

Health Care Counsel Blog
FDA’s Attempt to Regulate Lab-Developed Tests Struck Down in Federal Court
April 9, 2025
Emily Cowley Leongini, Wayne H. Matelski, Jack R. Bierig, Gayland O. Hethcoat II

On March 31, a judge in the Eastern District of Texas vacated the US Food and Drug Administration’s (FDA) rule that sought to regulate laboratory-developed tests (LDTs) as medical devices under the Federal Food, Drug, and Cosmetic Act (FDCA).

AI Law Blog
FDA Issues New Recommendations on Use of AI for Medical Devices, Drugs, and Biologics
January 21, 2025
Dan Jasnow, Wayne H. Matelski, Shoshana Golden

In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued two draft guidances on the use of artificial intelligence (AI) in the context of drugs, biologics, and medical devices.

Alerts
BIS Authorizes Medical Device Exports to Russia, Belarus, and Occupied Ukraine (With Strings Attached)
April 30, 2024
Derek Ha, Kay C. Georgi

License Exception MED, published by the US Department of Commerce’s Bureau of Industry and Security (BIS) on April 25, authorizes the export, reexport, or in-country transfer of EAR99 “medical devices” to non-military hospitals but comes with new restrictions and due diligence requirements.

Alerts
Devil Is Always in the Details: FDA Updates Device Classification Regulations To Remove Certain Software Functions
April 20, 2021

On April 19, 2021, FDA issued a final rule that amends its device classification regulations to exclude from regulation as a medical device certain types of software functions for certain products.

Alerts
EUAs for Laboratory Developed COVID-19 Tests Will No Longer Be Reviewed by the FDA
October 9, 2020
Wayne H. Matelski

The FDA announced on October 7 that it will no longer review requests for Emergency Use Authorizations (EUAs) for COVID-19 laboratory developed tests – so called “LDTs.” This is a substantial change in Agency policy.

Alerts
COVID-19 Tests No Longer Need Authorization by FDA for Marketing
August 20, 2020
Wayne H. Matelski

In the Food and Drug area, we don’t often get dramatic changes in FDA policies, but an announcement from the Secretary of HHS, published on August 18, appears to be just such a dramatic change.

Alerts
How to Tell if Your COVID-19 Test Is Authorized by the FDA
June 18, 2020
Wayne H. Matelski

FDA’s website allows you to determine if a particular COVID-19 test has been reviewed by the FDA.

Alerts
FDA Authorizes First Genomic Sequencing COVID-19 Test
June 12, 2020
Wayne H. Matelski

On June 10, 2020, the FDA issued an emergency use authorization (EUA) for the first molecular diagnostic test that can generate information about the genomic sequence of the COVID-19 virus.

Alerts
PPE Update: FDA Revises Policy for Face Masks and Respirators During COVID-19 Pandemic
May 30, 2020

FDA has yet again revised its Enforcement Policy for the US importation and distribution of face masks and respirators during the COVID-19 pandemic.

Alerts
FDA Removes Certain Serology/Antibody Tests From the Market
May 26, 2020
Wayne H. Matelski

The FDA has just published a list of certain already-on-the-market serology/antibody tests from commercial manufacturers that should not be distributed unless and until an Emergency Use Authorization (EUA) is issued for the test.

Alerts
USDA and FDA Address Equipment Shortages to Protect Nation’s Food Supply
May 26, 2020
Wayne H. Matelski

On Friday, May 22, 2020, the USDA and FDA jointly released recommendations to address shortages of personal protective equipment (PPE), cloth face coverings, disinfectants, and sanitation supplies in the food and agriculture industries.

Alerts
COVID-19 Primer: Antigen, PCR, and Serology Tests
May 12, 2020
Wayne H. Matelski

“Testing, Testing, Testing” is the new mantra. The politicians and the press are full of the few reports of testing successes and the many reports of testing failures throughout the country and around the world.

Alerts
First Saliva Test Approved for At-Home Use for a COVID-19 Diagnostic Test
May 11, 2020
Wayne H. Matelski

On May 8, 2020, the FDA announced that it had authorized the first COVID-19 diagnostic test that can be used to collect saliva in the home.

Alerts
FDA Revises EUA for Respirators Manufactured in China
May 8, 2020

What one hand giveth, the other can taketh away. That adage comes to mind when reviewing FDA’s most recent action with respect to the importation and distribution of KN95 and other respirator masks manufactured in China. 

Alerts
COVID-19: The Push for Serological Antibody Testing With a High Degree of Accuracy and Reliability
May 7, 2020
Robert G. Edwards, Ph.D.

The presence in the blood of antibodies specific to the novel coronavirus may help identify those who were unknowingly exposed to the virus but remained asymptomatic, those who were symptomatic but have fully recovered, and, as a result, those who might now have immunity, at least temporarily. Howev

Alerts
Big Changes in FDA’s Serology/Antibody Testing Requirements
May 5, 2020
Wayne H. Matelski

On May 4, 2020, the FDA issued new Guidance that drastically changes the requirements for serology/antibody tests for the COVID-19 epidemic.

Alerts
FDA Issues EUA for Face Masks
April 22, 2020

This updates our prior Alerts regarding the importation and distribution of face masks during the COVID-19 pandemic. The daily news is replete with reports of various types of masks and other personal protective equipment (PPE) that pose supply challenges due to high demand.

Alerts
COVID-19: Antibody Tests for Everybody?
April 21, 2020
Wayne H. Matelski

As the United States begins to see positive signs that mitigation efforts such as stay-at-home orders and social distancing are working, the question of when people can return to work and resume normal activities is one of the most critical issues facing the country – and indeed the world. 

Alerts
FDA Issues Enforcement Policy for Telethermographic Systems During COVID-19
April 20, 2020

FDA continues at a relatively fast clip to issue policies intended to help solve a dire problem: the ongoing need to expand the availability of certain medical products in the US that are critical to addressing the COVID-19 pandemic.

Alerts
Update: Importation and Distribution of Face Shields and Respirators During COVID-19 Pandemic
April 6, 2020

This updates our prior Alert regarding the importation and distribution of respirators and other masks to be used to meet the significant US health care challenges posed by the COVID-19 pandemic.

Alerts
FDA Issues Enforcement Policy for Gowns, Other Apparel, and Gloves
March 30, 2020

As part of its ongoing effort to address the critical shortage of Personal Protective Equipment (PPE) needed to address the COVID-19 pandemic, FDA has issued an Enforcement Policy to help expand the availability of surgical apparel for healthcare professionals, including gowns and gloves.

Alerts
FDA Issues Enforcement Policy for Ventilators and Other Respirators
March 30, 2020

As part of its effort to address the shortage of medical equipment needed to address the COVID-19 pandemic, FDA has issued a new Enforcement Policy announcing flexibility in some of the regulatory requirements for ventilators, accessories, and other respiratory devices.

Alerts
If Successful, Teva Suit Could Decrease Generic Competition
March 27, 2020
Kevin M. Nelson

Teva Pharmaceuticals filed suit against the United States Food and Drug Administration (FDA) alleging that its glatiramer (Copaxone) falls under the revised definition of a “biological product” and should be transitioned to the system established by the Biologics Price Competition and Innovation Act of 2009 (BPCIA).

Alerts
Update: Importation and Distribution of Face Masks and Respirators During the COVID-19 Pandemic
March 27, 2020

This updates our prior Alert regarding the importation and distribution of face masks and respirators to be used to meet the significant US health care challenges posed by the COVID-19 pandemic.

Alerts
New FDA Enforcement Policy for Non-Invasive Remote Patient Monitoring Devices During the COVID-19 Pandemic
March 26, 2020

FDA has issued a new Enforcement Policy that allows manufacturers of certain FDA-cleared non-invasive devices to expand their use for healthcare professionals to monitor patients remotely during the COVID-19 pandemic.

Pagination

  • Current page 1
  • Page 2
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2025 ArentFox Schiff LLP. All Rights Reserved.

Back to Top